Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Hims & Hers Health, Inc. (HIMS : NYSE)
 
 • Company Description   
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.

Number of Employees: 2,442

 
 • Price / Volume Information   
Yesterday's Closing Price: $14.52 Daily Weekly Monthly
20 Day Moving Average: 38,411,464 shares
Shares Outstanding: 227.94 (millions)
Market Capitalization: $3,309.67 (millions)
Beta: 2.56
52 Week High: $70.43
52 Week Low: $13.74
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -46.40% -45.93%
12 Week -62.96% -63.01%
Year To Date -55.28% -55.50%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2269 CHESTNUT STREET SUITE 523
-
SAN FRANCISCO,CA 94123
USA
ph: 415-851-0195
fax: -
investors@forhims.com http://www.hims.com
 
 • General Corporate Information   
Officers
Andrew Dudum - Chief Executive Officer
Oluyemi Okupe - Chief Financial Officer
Irene Becklund - Chief Accounting Officer
Delos Cosgrove - Director
Anja Manuel - Director

Peer Information
Hims & Hers Health, Inc. (HLIS)
Hims & Hers Health, Inc. (AZTA)
Hims & Hers Health, Inc. (APYI)
Hims & Hers Health, Inc. (RNVA)
Hims & Hers Health, Inc. (HMSY)
Hims & Hers Health, Inc. (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 433000106
SIC: 8011
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 12/01/25
Next Expected EPS Date: 05/04/26
Share - Related Items
Shares Outstanding: 227.94
Most Recent Split Date: (:1)
Beta: 2.56
Market Capitalization: $3,309.67 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.02 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.53 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 9.81% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 05/04/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 27.26
Trailing 12 Months: 29.04
PEG Ratio: 2.78
Price Ratios
Price/Book: 6.10
Price/Cash Flow: 17.35
Price / Sales: 1.41
EPS Growth
vs. Year Ago Period: -36.36%
vs. Previous Quarter: 16.67%
Sales Growth
vs. Year Ago Period: 28.41%
vs. Previous Quarter: 3.15%
ROE
12/31/25 - 22.48
09/30/25 - 24.67
06/30/25 - 26.26
ROA
12/31/25 - 7.02
09/30/25 - 9.37
06/30/25 - 13.06
Current Ratio
12/31/25 - 1.90
09/30/25 - 1.88
06/30/25 - 4.98
Quick Ratio
12/31/25 - 1.70
09/30/25 - 1.64
06/30/25 - 4.46
Operating Margin
12/31/25 - 5.35
09/30/25 - 6.05
06/30/25 - 6.62
Net Margin
12/31/25 - 5.47
09/30/25 - 6.05
06/30/25 - 9.63
Pre-Tax Margin
12/31/25 - 5.28
09/30/25 - 5.78
06/30/25 - 6.91
Book Value
12/31/25 - 2.38
09/30/25 - 2.55
06/30/25 - 2.49
Inventory Turnover
12/31/25 - 6.08
09/30/25 - 5.69
06/30/25 - 5.78
Debt-to-Equity
12/31/25 - 1.80
09/30/25 - 1.67
06/30/25 - 1.72
Debt-to-Capital
12/31/25 - 64.26
09/30/25 - 62.57
06/30/25 - 63.27
 

Powered by Zacks Investment Research ©